Lyme Science Blog
Oct 04

Fatigue can be overlooked as a “sign” of Lyme disease

Like
Visited 994 Times, 6 Visits today

What Does Lyme Disease Fatigue Feel Like?

Why Lyme disease can cause profound exhaustion
How fatigue may affect thinking and daily activity
Why symptoms sometimes persist after treatment

Lyme disease fatigue may feel like much more than ordinary tiredness. Patients may describe profound physical exhaustion, reduced stamina, mental fatigue, or an inability to recover after sleep. Fatigue can occur during early Lyme disease and may persist alongside pain, cognitive problems, sleep disruption, and other symptoms.

What does Lyme disease fatigue feel like?

In my clinical practice, patients often describe Lyme disease fatigue as a level of exhaustion that seems out of proportion to their activity. A short walk, routine household task, conversation, or period of concentration may leave them depleted.

Some patients feel physically heavy or weak. Others describe mental exhaustion, difficulty concentrating, slowed thinking, or an inability to remain productive. Sleep may not restore their usual energy.

Lyme disease fatigue may include:

  • Profound exhaustion despite adequate sleep
  • Reduced physical stamina
  • Mental fatigue or difficulty concentrating
  • Worsening after physical or cognitive activity
  • A need to rest during ordinary daily activities
  • Fatigue accompanied by pain, headaches, dizziness, or sleep problems

The experience varies considerably. Fatigue may be constant, fluctuate throughout the day, or worsen when other symptoms flare.

Why does Lyme disease cause fatigue?

The reasons for fatigue in Lyme disease are not completely understood. During early infection, fatigue may be part of the body’s inflammatory response.

Researchers at New York Medical College proposed that fatigue in patients with erythema migrans may be related to proinflammatory cytokines and other acute-phase proteins. They described fatigue as a possible component of the “acute sickness response.”1

When the immune system responds to infection, inflammatory signaling can contribute to fatigue, body aches, reduced activity, and a greater need for sleep.

In patients with persistent symptoms, fatigue may be more complex. Possible contributors include ongoing inflammation, immune dysregulation, sleep disruption, pain, neurologic involvement, autonomic dysfunction, medication effects, tick-borne coinfections, persistent infection in selected patients, or unrelated medical conditions.

How common is fatigue in early Lyme disease?

Wormser and colleagues evaluated 51 untreated adults with erythema migrans using three different measures of fatigue.1 Twenty-six patients, or 51%, reported some fatigue on a Visual Analogue Scale. Ten patients, or 19.6%, met the study threshold for severe fatigue on the 11-item Fatigue Severity Scale.

The strongest correlate of greater fatigue was having a larger number of accompanying symptoms. This suggests that fatigue in early Lyme disease often occurs as part of a broader illness rather than as an isolated complaint.

Can Lyme disease cause extreme fatigue?

Yes. Fatigue has been reported as one of the most common symptoms in studies of chronic neurologic Lyme disease, Lyme encephalopathy, post-Lyme disease, and Post-Treatment Lyme Disease Syndrome (PTLDS).2-7

Severe fatigue can interfere with work, school, exercise, household responsibilities, and social activity. A patient may appear well while struggling to complete activities that were previously routine.

This functional impact helps distinguish illness-related fatigue from the ordinary tiredness people experience after a busy day or inadequate sleep.

Can Lyme disease fatigue worsen after activity?

Some patients report that fatigue, cognitive difficulty, pain, dizziness, or other symptoms worsen after physical or mental activity. This delayed or prolonged worsening is sometimes described as post-exertional malaise (PEM). It differs from ordinary exercise-related tiredness because symptoms may be disproportionate to the activity and recovery may take longer than expected.

A 2023 systematic review compared symptoms reported in PTLDS with those associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The researchers found considerable symptom overlap, including prolonged fatigue, reduced activity, post-exertional malaise, unrefreshing sleep, cognitive problems, and orthostatic intolerance.11

The review included 18 PTLDS studies. In most of them, researchers reported at least four of the six major symptoms associated with ME/CFS. Fatigue and brain fog were among the most consistently reported symptoms.

This overlap does not prove that PTLDS and ME/CFS have the same underlying cause. It suggests that some patients may experience a similar pattern of fatigue, sleep disruption, cognitive difficulty, and worsening after exertion.

Can fatigue continue after Lyme disease treatment?

Some patients continue to experience fatigue after completing an initial course of antibiotics. PTLDS is a research definition applied to selected patients who develop persistent symptoms and functional impairment after appropriately treated Lyme disease.

Symptoms used in this definition may include fatigue, musculoskeletal pain in several areas, and cognitive complaints involving word finding, focus, concentration, or memory.6

In one prospective study, patients with an elevated level of the T-cell chemokine CCL19 after a three-week course of doxycycline had a substantially higher risk of developing PTLDS.6 The finding suggested that a persistent immune response may help identify patients at greater risk, but CCL19 is not currently a routine diagnostic test for persistent Lyme disease.

The mechanism responsible for continuing symptoms remains unsettled. PTLDS describes a pattern of illness but does not establish why an individual patient remains fatigued.

What did a prospective study find about persistent fatigue?

A prospective Belgian study followed patients with erythema migrans, patients with disseminated or late Lyme borreliosis, and controls.12

At six months, new or worsened fatigue was reported in 33.3% of the disseminated or late Lyme disease group, compared with 3.2% of controls. At 12 months, the rates were 45.5% and 3.7%, respectively.

The researchers estimated that PTLDS developed in 5.9% of patients with erythema migrans and 20.9% of patients with disseminated or late Lyme borreliosis.

However, the disseminated and late Lyme disease group included only 15 patients, resulting in wide confidence intervals. The findings should be interpreted cautiously but support further investigation into whether the stage and severity of Lyme disease influence the risk of prolonged fatigue.

Can antibiotic treatment improve persistent Lyme disease fatigue?

Two randomized clinical trials reported improvement in severe fatigue among some patients with persistent symptoms following Lyme disease treatment.

In the STOP-LD trial, improvement at six months on the 11-item Fatigue Severity Scale was reported in 64% of patients who received one month of intravenous ceftriaxone, compared with 18.5% who received intravenous placebo.5

In a trial involving patients with Lyme encephalopathy, a post hoc analysis found improvement at six months on the Fatigue Severity Scale in 66.7% of patients who received 10 weeks of intravenous ceftriaxone, compared with 25% who received intravenous placebo.4

These findings require careful interpretation. The STOP-LD trial found improvement in severe fatigue but not the expected cognitive benefit, and treatment-related adverse events occurred. In the Lyme encephalopathy trial, cognitive improvement was not sustained after treatment ended, while the fatigue finding came from a post hoc analysis. Intravenous treatment also carries meaningful risks.

Treatment decisions should not be based on fatigue alone. They should consider the original diagnosis, previous treatment, objective findings, symptom pattern, treatment response, possible coinfections, competing diagnoses, and the risks and potential benefits of additional therapy.

How is Lyme disease fatigue measured?

Fatigue can be difficult to quantify because it is based largely on the patient’s experience. Researchers have used several tools to evaluate its severity and functional impact.

Wormser and colleagues used a Visual Analogue Scale, the 11-item Fatigue Severity Scale, and a question from the 36-item Short Form General Health Survey. The three measures were positively correlated with one another.1

Visual Analogue Scale used to measure fatigue

In my clinical practice, I have used a 0-to-10 Visual Analogue Scale for more than 25 years to follow fatigue in patients with suspected Lyme disease. A simple score does not explain the cause, but it can help determine whether fatigue is improving, worsening, or remaining unchanged.

Why should other causes of fatigue be considered?

Fatigue is not specific to Lyme disease. It has also been described in fibromyalgia, multiple sclerosis, inflammatory disorders, sleep disorders, endocrine disease, anemia, medication reactions, depression, and many other conditions.8-10

A patient with persistent or extreme fatigue may need an evaluation for alternative or overlapping causes. Depending on the clinical picture, this may include reviewing sleep quality, medications, blood counts, thyroid function, nutritional deficiencies, other infections, pain, mood, and autonomic symptoms.

Patients previously treated for Lyme disease may also require reassessment of the original diagnosis, adequacy of treatment, exposure to additional tick bites, possible coinfections, and the development of unrelated illnesses.

The presence of another possible cause should not automatically exclude Lyme disease. Likewise, a history of Lyme disease should not prevent a clinician from investigating other treatable conditions.

Frequently Asked Questions

Does Lyme disease make you tired?

Yes. Fatigue is a recognized symptom of Lyme disease and may occur during early infection, neurologic illness, or persistent illness after treatment. Its severity ranges from mild tiredness to exhaustion that substantially limits daily functioning.

What does Lyme disease fatigue feel like?

Lyme disease fatigue may feel like profound physical or mental exhaustion that is disproportionate to activity and not fully relieved by sleep. Some patients also experience reduced stamina, cognitive difficulty, weakness, pain, dizziness, or worsening after exertion.

Can Lyme disease cause extreme fatigue?

Yes. Some patients develop severe fatigue that interferes with work, school, exercise, household responsibilities, or social activity. Because extreme fatigue has many possible causes, it requires a careful medical evaluation.

How long does Lyme disease fatigue last?

The duration varies. Fatigue may improve during or after treatment, while some patients experience symptoms for months or longer. Recovery may depend on the stage of illness, treatment timing, neurologic involvement, coinfections, sleep, pain, autonomic dysfunction, and other contributing conditions.

Clinical Takeaway

Lyme disease fatigue may be profound, persistent, and disabling. It may affect physical endurance, cognitive function, sleep, work, and the ability to complete ordinary activities.

Fatigue alone cannot determine whether a patient has active Lyme disease, PTLDS, a coinfection, an inflammatory response, or another medical condition. The symptom should be evaluated within the patient’s complete clinical history.

Persistent Lyme disease fatigue deserves careful reassessment, structured follow-up, and an individualized evaluation of all potentially treatable causes while patients work toward recovery from Lyme disease.

Related Articles

Lyme Disease Symptoms Guide
Persistent Lyme Disease Overview
Autonomic Dysfunction and Lyme Disease
Lyme Disease Test Accuracy

References

  1. Wormser GP, Sudhindra P, Lopez E, et al. Fatigue in patients with erythema migrans. Diagn Microbiol Infect Dis. 2016;86(3):322-326.
  2. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323(21):1438-1444.
  3. Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis. 1999;180(2):377-383.
  4. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003.
  5. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): A randomized double-masked clinical trial. Neurology. 2003;60(12):1923-1930.
  6. Aucott JN, Soloski MJ, Rebman AW, et al. CCL19 as a chemokine risk factor for post-treatment Lyme disease syndrome: A prospective clinical cohort study. Clin Vaccine Immunol. 2016;23(9):757-766.
  7. Weitzner E, Visintainer P, Wormser GP. Comparison of males versus females with culture-confirmed early Lyme disease at presentation and at 11–20 years after diagnosis. Diagn Microbiol Infect Dis. 2016;85(4):493-495.
  8. Gielissen MF, Knoop H, Servaes P, et al. Differences in the experience of fatigue in patients and healthy controls: Patients’ descriptions. Health Qual Life Outcomes. 2007;5:36.
  9. Parrish BP, Zautra AJ, Davis MC. The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis. Health Psychol. 2008;27(6):694-702.
  10. Mengshoel AM. Life strain-related tiredness and illness-related fatigue in individuals with ankylosing spondylitis. Arthritis Care Res (Hoboken). 2010;62(9):1272-1277.
  11. Bai NA, Richardson CS. Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis. Chronic Dis Transl Med. 2023;9(3):183-190.
  12. Geebelen L, Lernout T, Devleesschauwer B, et al. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: A prospective cohort study in Belgium (2016–2020). BMC Infect Dis. 2022;22:756.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention

Related Posts

Leave a Comment

Your email address will not be published. Required fields are marked *